Accelerate Diagnostics Inc (AXDX) - Medical Equipment - Deals and Alliances Profile
October 2018
34
About the Report
About the Report
Summary
Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in vitro diagnostic platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients suspected of bacteremia or fungemia. Accelerate uses its proprietary molecular identification methods and morphokinetic cellular analysis to provide faster quantitative ID/AST results. The company has a manufacturing facility in Tucson, Arizona. Accelerate is headquartered in Tucson, Arizona, the US.
Accelerate Diagnostics Inc (AXDX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Accelerate Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accelerate Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 10
Equity Offering 11
Accelerate Diagnostics Raises USD79.3 Million in Public Offering of Shares 11
Accelerate Diagnostics Raises USD109.3 Million in Public Offering of Shares 13
Accelerate Diagnostics Completes Rights Offering Of Shares For USD 45 Million 15
Accelerate Diagnostics Files Registration Statement For Public Offering Of Securities For Up To USD 150 Million 16
Accelerate Diagnostics Completes Rights Offering Of Shares For USD 20 Million 17
Accelr8 Technology Completes Private Placement Of Shares For USD 14.4 Million 18
Debt Offering 19
Accelerate Diagnostics Prices Private Placement of 2.5% Notes Due 2023 for USD150 Million 19
Accelerate Diagnostics Inc-Key Competitors 20
Accelerate Diagnostics Inc-Key Employees 21
Accelerate Diagnostics Inc-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 06, 2018: Accelerate Diagnostics reports Q2 2018 financial results 23
May 09, 2018: Accelerate Diagnostics reports Q1 2018 financial results 24
Feb 15, 2018: Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017 25
Nov 02, 2017: Accelerate Diagnostics reports Q3 2017 financial results 26
Aug 03, 2017: Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements 27
May 03, 2017: Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017 28
Corporate Communications 29
Sep 27, 2018: Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa 29
Nov 16, 2017: Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors 30
Jul 31, 2017: Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer 31
Mar 15, 2017: Accelerate Diagnostics Names Tom Brown to Board of Directors 32
Product News 33
May 30, 2017: Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List of Figure
List of Figures
Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Accelerate Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accelerate Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accelerate Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accelerate Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Accelerate Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 10
Accelerate Diagnostics Raises USD79.3 Million in Public Offering of Shares 11
Accelerate Diagnostics Raises USD109.3 Million in Public Offering of Shares 13
Accelerate Diagnostics Completes Rights Offering Of Shares For USD 45 Million 15
Accelerate Diagnostics Files Registration Statement For Public Offering Of Securities For Up To USD 150 Million 16
Accelerate Diagnostics Completes Rights Offering Of Shares For USD 20 Million 17
Accelr8 Technology Completes Private Placement Of Shares For USD 14.4 Million 18
Accelerate Diagnostics Prices Private Placement of 2.5% Notes Due 2023 for USD150 Million 19
Accelerate Diagnostics Inc, Key Competitors 20
Accelerate Diagnostics Inc, Key Employees 21
Accelerate Diagnostics Inc, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.